https://www.healthreportequatorialguinea.com/article/912304549-the-25th-tunnel-to-towers-nyc-5k-run-walk-is-set-for-september-27th Health Report Equatorial Guinea en PressRelease 2026-05-12T17:58:10+00:00 The 25th Tunnel to Towers NYC 5K Run & Walk is Set for September 27th https://ml.globenewswire.com/media/NDYwYWU5NTAtODg3Yi00MzQ5LTllZDktMGQzODc5YTQ3YjUwLTExMzQ0NDMtMjAyNi0wNS0xMi1lbg==/tiny/Stephen-Siller-Tunnel-To-Tower.png https://www.healthreportequatorialguinea.com/article/912304451-update-skye-bioscience-reports-first-quarter-2026-financial-results-and-business-update Health Report Equatorial Guinea en PressRelease 2026-05-12T17:33:53+00:00 UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://www.healthreportequatorialguinea.com/article/912282903-recordati-strong-momentum-of-the-group-continues-into-the-first-quarter-of-2026-net-revenue-4-9-ebitda-1-5-0-adjusted-net-income-2-7-2 Health Report Equatorial Guinea en PressRelease 2026-05-12T16:46:39+00:00 RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2% https://ml-eu.globenewswire.com/media/a64917fc-da51-47f4-a36a-dc04b029ed8b/small/r-logo2023-rgb-3-png.png https://www.healthreportequatorialguinea.com/article/912282909-recordati-il-forte-slancio-del-gruppo-prosegue-nel-primo-trimestre-del-2026-ricavi-netti-4-9-ebitda-1-5-0-utile-netto-rettificato-2-7-2 Health Report Equatorial Guinea en PressRelease 2026-05-12T16:46:39+00:00 RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2% https://ml-eu.globenewswire.com/media/e91474c3-cf48-41ba-ba26-b56e8278779f/small/r-logo2023-rgb-3-png.png https://www.healthreportequatorialguinea.com/article/912283056-to-your-health-launches-innovative-online-protein-intake-calculator Health Report Equatorial Guinea en PressRelease 2026-05-12T16:42:00+00:00 To Your Health Launches Innovative Online Protein Intake Calculator https://ml.globenewswire.com/media/08b8a73d-cd8f-4090-9c45-b598e5c48df4/small/to-your-health-logo.png https://www.healthreportequatorialguinea.com/article/912283060-atum-s-new-lock-in-platform-solves-bispecific-mispairing Health Report Equatorial Guinea en PressRelease 2026-05-12T16:37:00+00:00 ATUM’s New Lock-In Platform Solves Bispecific Mispairing https://ml.globenewswire.com/media/874d4e0a-920f-43ea-b167-d50dc78bc154/small/atum-logo.png https://www.healthreportequatorialguinea.com/article/912283027-sacramento-kings-and-sutter-health-announce-strategic-partnership Health Report Equatorial Guinea en PressRelease 2026-05-12T16:30:00+00:00 Sacramento Kings and Sutter Health Announce Strategic Partnership https://ml.globenewswire.com/media/MWIwNDMwZmMtODk1OS00MDdhLTk3NmYtOTYzMDM4NmEyM2JlLTUwMDE1MDYxNS0yMDI2LTA1LTEyLWVu/tiny/Sutter-Health.png https://www.healthreportequatorialguinea.com/article/912282882-high-diet-surpasses-1-700-customer-reviews-as-users-praise-personalized-high-protein-meal-plans Health Report Equatorial Guinea en PressRelease 2026-05-12T16:09:57+00:00 High Diet Surpasses 1,700 Customer Reviews as Users Praise Personalized High-Protein Meal Plans https://ml-eu.globenewswire.com/media/8189e2bb-1b29-42e3-8d37-b550802925ee/medium/high-diet.png https://www.healthreportequatorialguinea.com/article/912283071-tevogen-announces-3-million-private-investment-at-8-per-share-a-14-premium-from-latest-market-close Health Report Equatorial Guinea en PressRelease 2026-05-12T15:45:00+00:00 Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close https://ml.globenewswire.com/media/679fef4d-f32f-46a2-9452-c31af5cf4597/small/tevogen-logo-newswire-png.png https://www.healthreportequatorialguinea.com/article/912263202-american-urological-association-releases-advanced-prostate-cancer-guideline-amendment Health Report Equatorial Guinea en PressRelease 2026-05-12T14:55:21+00:00 American Urological Association Releases Advanced Prostate Cancer Guideline Amendment https://ml.globenewswire.com/media/N2FjMTc1MjQtMGNjMS00MjYyLWFjMWEtNjliYjViOTAwNDI1LTEyNzYxOTAtMjAyNi0wNS0xMi1lbg==/tiny/American-Urological-Associatio.png https://www.healthreportequatorialguinea.com/article/912263125-syndax-highlights-12-revuforj-revumenib-abstracts-accepted-for-eha-2026-advancing-leadership-in-menin-inhibition Health Report Equatorial Guinea en PressRelease 2026-05-12T14:31:49+00:00 Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912262512-global-urinalysis-market-set-to-reach-usd-6-81-billion-by-2029-marketsandmarkets Health Report Equatorial Guinea en PressRelease 2026-05-12T14:30:00+00:00 Global Urinalysis Market Set to Reach USD 6.81 Billion by 2029 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.healthreportequatorialguinea.com/article/912263115-nexgel-to-report-first-quarter-2026-financial-results-on-may-15th Health Report Equatorial Guinea en PressRelease 2026-05-12T14:27:00+00:00 NEXGEL To Report First Quarter 2026 Financial Results on May 15th https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.healthreportequatorialguinea.com/article/912263057-extendicare-files-business-acquisition-report-in-connection-with-the-cbi-home-health-acquisition Health Report Equatorial Guinea en PressRelease 2026-05-12T14:06:34+00:00 Extendicare Files Business Acquisition Report in connection with the CBI Home Health Acquisition https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.healthreportequatorialguinea.com/article/912262575-telespecialists-expands-digital-healthcare-access-across-rural-communities-nationwide Health Report Equatorial Guinea en PressRelease 2026-05-12T14:00:00+00:00 TeleSpecialists Expands Digital Healthcare Access Across Rural Communities Nationwide https://ml.globenewswire.com/media/Nzc2ZWNlNjctOGI3Yi00MTVmLWExYWItOGJlN2E3YmMwMDQ3LTUwMDE0OTY0OS0yMDI2LTA1LTEyLWVu/tiny/TeleSpecialists.png https://www.healthreportequatorialguinea.com/article/912262649-truveta-and-knit-health-announce-collaboration-to-power-a-new-generation-of-clinical-ai Health Report Equatorial Guinea en PressRelease 2026-05-12T14:00:00+00:00 Truveta and Knit Health announce collaboration to power a new generation of clinical AI https://ml.globenewswire.com/media/NmQ2OWNjNTYtNTgwMy00YjI0LTlmYWMtZTQzYzkzM2YxMmNmLTEyNzUzNzQtMjAyNi0wNS0xMi1lbg==/tiny/Truveta.png https://www.healthreportequatorialguinea.com/article/912262678-liveworld-s-new-app-research-council-gives-brands-direct-access-to-frontline-np-and-pa-insights-to-improve-relevance-reach-and-roi Health Report Equatorial Guinea en PressRelease 2026-05-12T14:00:00+00:00 LiveWorld's New APP Research Council Gives Brands Direct Access to Frontline NP and PA Insights to Improve Relevance, Reach, and ROI https://ml.globenewswire.com/media/b26faeda-6846-4308-830c-e53ab023ba65/small/liveworld-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912263003-mental-health-awareness-month-tpn-health-solves-the-access-crisis-costing-self-insured-stakeholders-health-plans-and-members-the-care-they-deserve Health Report Equatorial Guinea en PressRelease 2026-05-12T14:00:00+00:00 Mental Health Awareness Month: TPN.health Solves the Access Crisis Costing Self-Insured Stakeholders, Health Plans and Members the Care They Deserve https://ml.globenewswire.com/media/7f287fef-0e9e-4b21-b184-be4db60a5c50/small/tpn-health-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912262589-becker-s-names-leap-distributors-ceo-allen-mason-to-2026-great-leaders-in-healthcare-list Health Report Equatorial Guinea en PressRelease 2026-05-12T13:47:00+00:00 Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List https://ml.globenewswire.com/media/NjA3MGZmNGUtMzA4NS00ZTMwLTlhMzItYjBmN2E4ODQ0ZGY1LTEzMDY0NDctMjAyNi0wNS0xMi1lbg==/tiny/Leap-Distributors.png https://www.healthreportequatorialguinea.com/article/912262938-kura-oncology-and-kyowa-kirin-to-present-updated-frontline-ziftomenib-7-3-combination-data-at-eha-2026-congress Health Report Equatorial Guinea en PressRelease 2026-05-12T13:40:16+00:00 Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.healthreportequatorialguinea.com/article/912245475-aquestive-therapeutics-completes-150-million-debt-refinancing-with-oaktree Health Report Equatorial Guinea en PressRelease 2026-05-12T13:31:25+00:00 Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree https://ml.globenewswire.com/media/e0b65f93-9565-43d7-a6ff-88b8cbd6adea/small/aquestive-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244503-agios-submits-snda-to-fda-for-u-s-accelerated-approval-of-mitapivat-in-sickle-cell-disease Health Report Equatorial Guinea en PressRelease 2026-05-12T13:31:00+00:00 Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.healthreportequatorialguinea.com/article/912245337-first-real-world-evidence-study-of-rytelo-imetelstat-in-lower-risk-myelodysplastic-syndromes-lr-mds-to-be-presented-at-eha-2026 Health Report Equatorial Guinea en PressRelease 2026-05-12T13:31:00+00:00 First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026  https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912243550-evaxion-to-present-new-data-for-evx-04-an-off-the-shelf-therapeutic-vaccine-for-acute-myeloid-leukemia-at-the-eha-2026-congress Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.healthreportequatorialguinea.com/article/912244021-beam-therapeutics-to-present-updated-biomarker-data-from-phase-1-2-beacon-trial-further-underscoring-risto-cel-s-ability-to-restore-red-blood-cell Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244194-cogent-biosciences-announces-multiple-presentations-at-the-european-hematology-association-eha-2026-congress Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.healthreportequatorialguinea.com/article/912244306-disc-medicine-announces-multiple-presentations-across-portfolio-at-the-european-hematology-association-eha-2026-congress Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244316-caribou-biosciences-to-highlight-vispa-cel-and-cb-011-programs-during-oral-presentations-at-the-2026-european-hematology-association-eha-annual Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting https://ml.globenewswire.com/media/9cd3169e-5a07-44f7-b820-b6f4fff6e4d1/small/caribou-logo-png.png https://www.healthreportequatorialguinea.com/article/912244517-blossomhill-therapeutics-to-present-initial-clinical-dose-escalation-data-from-the-phase-1-1b-trial-of-bh-30236-in-patients-with-r-r-aml-or-hr-mds-at Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026 https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244522-agios-to-present-new-data-at-eha-2026-reinforcing-the-significant-therapeutic-impact-of-mitapivat-across-multiple-rare-hemolytic-anemias Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.healthreportequatorialguinea.com/article/912244899-ajax-therapeutics-announces-oral-presentation-of-clinical-results-from-ajx-101-a-phase-i-study-of-aj1-11095-a-first-in-class-type-ii-jak2-inhibitor Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress https://ml.globenewswire.com/media/4a1616ad-5fbb-4df2-8270-094f5294c667/small/ajax-gradient-logo-rgb-large-png.png https://www.healthreportequatorialguinea.com/article/912245006-cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.healthreportequatorialguinea.com/article/912245010-cellectis-pr-sentera-des-donn-es-cliniques-sur-lasm-cel-et-ti-cel-au-congr-s-annuel-de-l-eha-2026 Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.healthreportequatorialguinea.com/article/912245263-independent-cleveland-clinic-review-finds-no-clinically-significant-cardiotoxicity-with-moleculin-s-annamycin-in-r-r-aml-patients-dosed-beyond Health Report Equatorial Guinea en PressRelease 2026-05-12T13:30:00+00:00 Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.healthreportequatorialguinea.com/article/912244197-payzen-report-healthcare-financial-pressures-mount-as-73-of-systems-elevate-patient-payment-balances-to-a-top-priority Health Report Equatorial Guinea en PressRelease 2026-05-12T13:15:00+00:00 PayZen Report: Healthcare Financial Pressures Mount as 73% of Systems Elevate Patient Payment Balances to a Top Priority https://ml.globenewswire.com/media/22679992-a395-40a3-9e05-2da99e869af5/small/payzen-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244812-four-winners-selected-in-perfectserve-s-2026-nurses-of-note-awards-program Health Report Equatorial Guinea en PressRelease 2026-05-12T13:05:00+00:00 Four Winners Selected in PerfectServe’s 2026 Nurses of Note Awards Program https://ml.globenewswire.com/media/3a42b331-2462-49bf-8760-8ac24410cc52/medium/winners-announced-for-perfectserve-s-2026-nurses-of-note-awa.jpg https://www.healthreportequatorialguinea.com/article/912244237-ontra-launches-ai-powered-ddq-solution-to-accelerate-investor-diligence-for-private-markets-firms Health Report Equatorial Guinea en PressRelease 2026-05-12T13:02:00+00:00 Ontra Launches AI-Powered DDQ Solution to Accelerate Investor Diligence for Private Markets Firms https://ml.globenewswire.com/media/ea2f73c7-a69a-43fc-a08c-0aa1239f582e/small/ontra-horizontal-black-1-png.png https://www.healthreportequatorialguinea.com/article/912243624-resolution-therapeutics-to-showcase-key-preclinical-data-on-its-regenerative-macrophage-therapy-rmt-rtx001-in-oral-presentation-at-asgct-2026 Health Report Equatorial Guinea en PressRelease 2026-05-12T13:00:00+00:00 Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026 https://ml-eu.globenewswire.com/media/9482740b-de8b-45a4-b278-7f5f9c3797c0/small/high-resolution-logo-png.png https://www.healthreportequatorialguinea.com/article/912244008-jenavalve-appoints-dave-haan-as-vice-president-of-clinical-affairs Health Report Equatorial Guinea en PressRelease 2026-05-12T13:00:00+00:00 JenaValve Appoints Dave Haan as Vice President of Clinical Affairs https://ml.globenewswire.com/media/a1ab2446-a463-4b8f-bc18-26a5ca117176/small/jv-logo-h-rgb-l-1607-png.png https://www.healthreportequatorialguinea.com/article/912244218-muscular-dystrophy-association-announces-100-000-investment-to-advance-lgmd-care-at-leading-mda-care-centers-with-bridgebio Health Report Equatorial Guinea en PressRelease 2026-05-12T13:00:00+00:00 Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio https://ml.globenewswire.com/media/ZGM3NWNhNjUtZWY5My00OGEwLWJjYWUtZGEyNjViOWZjNDdjLTEwOTg0NjYtMjAyNi0wNS0xMi1lbg==/tiny/Muscular-Dystrophy-Association.png https://www.healthreportequatorialguinea.com/article/912244310-connect-biopharma-reports-first-quarter-2026-financial-results-and-provides-business-update Health Report Equatorial Guinea en PressRelease 2026-05-12T13:00:00+00:00 Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/831dcc2a-691d-4cad-813e-855f9fa2bd69/small/connect-logo-cmyk-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244539-liveworld-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-12T13:00:00+00:00 LiveWorld Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b26faeda-6846-4308-830c-e53ab023ba65/small/liveworld-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244912-prognomiq-announces-breakthrough-results-for-the-early-detection-of-lung-cancer-in-ongoing-real-world-study-for-its-novel-blood-test Health Report Equatorial Guinea en PressRelease 2026-05-12T13:00:00+00:00 PrognomiQ Announces Breakthrough Results for the Early Detection of Lung Cancer in Ongoing Real-World Study for Its Novel Blood Test https://ml.globenewswire.com/media/96409eec-09cb-41f0-af6f-66ec52af7f62/small/prognomiq-logo-rgb-jpg.jpg https://www.healthreportequatorialguinea.com/article/912245065-clearmind-medicine-reaches-important-clinical-milestone-20-participants-now-treated-in-ongoing-phase-i-iia-trial-of-cmnd-100-for-alcohol-use-disorder Health Report Equatorial Guinea en PressRelease 2026-05-12T12:41:00+00:00 Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244802-fortis-life-sciences-awards-2026-abnano-vhh-discovery-grant-to-deliver-biosciences-for-targeted-drug-delivery-research Health Report Equatorial Guinea en PressRelease 2026-05-12T12:40:00+00:00 Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://www.healthreportequatorialguinea.com/article/912243815-envue-medical-secures-three-year-contract-renewal-at-12-hospital-u-s-health-network-as-the-envue-navigation-platform-becomes-standard-of-care Health Report Equatorial Guinea en PressRelease 2026-05-12T12:37:00+00:00 ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244004-akari-therapeutics-secures-key-european-patent-for-its-novel-rna-splicing-modulator-adc-payload-strengthening-global-ip-estate-for-all-major-global Health Report Equatorial Guinea en PressRelease 2026-05-12T12:33:00+00:00 Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244201-20-20-biolabs-exclusively-licenses-psa-velocity-algorithm-from-the-university-of-south-carolina Health Report Equatorial Guinea en PressRelease 2026-05-12T12:31:00+00:00 20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png https://www.healthreportequatorialguinea.com/article/912243861-adagene-to-participate-in-two-upcoming-investor-conferences Health Report Equatorial Guinea en PressRelease 2026-05-12T12:30:00+00:00 Adagene to Participate in Two Upcoming Investor Conferences https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://www.healthreportequatorialguinea.com/article/912244371-lexicon-pharmaceuticals-to-present-at-the-4th-annual-h-c-wainwright-bioconnect-investor-conference Health Report Equatorial Guinea en PressRelease 2026-05-12T12:30:00+00:00 Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244725-orchestra-biomed-targeting-backbeat-trial-enrollment-completion-by-end-of-q3-2026-and-data-presentation-in-q2-2027 Health Report Equatorial Guinea en PressRelease 2026-05-12T12:30:00+00:00 Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027 https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.healthreportequatorialguinea.com/article/912244831-oncotelic-therapeutics-inc-otcqb-otlc-proprietary-n2b-system-may-offer-key-to-unlocking-next-gen-therapies Health Report Equatorial Guinea en PressRelease 2026-05-12T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244942-mindbio-therapeutics-corp-cse-mbio-otcqb-mbqif-leveraging-ai-voice-analysis-to-develop-intoxication-detection Health Report Equatorial Guinea en PressRelease 2026-05-12T12:30:00+00:00 MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection https://ml.globenewswire.com/media/ef429fe7-9cc2-4785-8e91-97fe534a4cd1/small/mbio-2048x537-png.png https://www.healthreportequatorialguinea.com/article/912244950-surenano-science-ltd-cse-sure-otcqb-surnf-advancing-a-differentiated-next-gen-glp-1-platform Health Report Equatorial Guinea en PressRelease 2026-05-12T12:30:00+00:00 SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform https://ml.globenewswire.com/media/4e983dfa-f169-46a5-ba21-ed1d05a90830/small/surenano-logo-png.png https://www.healthreportequatorialguinea.com/article/912243561-boehringer-ingelheim-licenses-preclinical-antibody-program-from-immunitas-therapeutics-to-advance-treatments-for-chronic-inflammatory-diseases Health Report Equatorial Guinea en PressRelease 2026-05-12T12:05:00+00:00 Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.healthreportequatorialguinea.com/article/912244222-crb-project-honored-as-2026-ispe-facility-of-the-year-awards-winner Health Report Equatorial Guinea en PressRelease 2026-05-12T12:05:00+00:00 CRB Project Honored as 2026 ISPE Facility of the Year Awards Winner https://ml.globenewswire.com/media/ODdhNWE1YWYtYzhkMy00NzA3LTk0OWItNzE4Njk0MDhmNWM3LTUwMDEzMTU2Ni0yMDI2LTA1LTEyLWVu/tiny/CRB-Group-Inc-.png https://www.healthreportequatorialguinea.com/article/912243697-flyte-activates-high-frequency-preakness-flight-program-deploying-fleet-to-serve-strong-northeast-demand Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912243779-imunon-reports-first-quarter-2026-financial-results-and-provides-business-update Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/acf78e45-a45b-456b-93e3-0e39f2122826/small/logo-png.png https://www.healthreportequatorialguinea.com/article/912243822-invitria-presents-new-data-at-asgct-2026-on-recombinant-human-serum-albumin-for-higher-lentiviral-vector-titers-and-improved-cell-therapy Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 InVitria Presents New Data at ASGCT 2026 on Recombinant Human Serum Albumin for Higher Lentiviral Vector Titers and Improved Cell Therapy Manufacturing https://ml.globenewswire.com/media/a765699d-9866-4c97-be6f-7c3390501d12/small/invitria-logo-performance-defined-800-x-400-px-png.png https://www.healthreportequatorialguinea.com/article/912243932-opko-health-s-modex-therapeutics-will-present-data-demonstrating-in-vivo-car-t-cell-generation-and-deep-b-cell-depletion-in-preclinical-studies Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.healthreportequatorialguinea.com/article/912243968-ascentage-pharma-to-participate-in-three-upcoming-investor-conferences Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Ascentage Pharma to Participate in Three Upcoming Investor Conferences https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.healthreportequatorialguinea.com/article/912244139-pmv-pharmaceuticals-reports-first-quarter-2026-financial-results-and-corporate-highlights Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/856eb6a7-75a1-45e1-8b0e-e50c81bf0d62/small/pmv-logo-new-png.png https://www.healthreportequatorialguinea.com/article/912244178-cloudbreak-pharma-to-present-at-the-stifel-2026-virtual-ophthalmology-forum Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum https://ml.globenewswire.com/media/a68e17c2-8a7a-44cf-bf9d-22382ad4109d/small/cloudbreak-pharma-logo-file-png.png https://www.healthreportequatorialguinea.com/article/912244216-sol-sence-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Solésence Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/cd3e5e4e-9567-4a86-8f44-900ffeb29d33/small/solesence-fullcolor-300dpi-social-002-1-png.png https://www.healthreportequatorialguinea.com/article/912244299-corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244347-rhythm-pharmaceuticals-announces-new-data-presentations-at-the-2026-european-congress-of-endocrinology Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244420-cerevance-completes-enrollment-in-pivotal-phase-3-parkinson-s-disease-trial-and-closes-oversubscribed-20-million-series-c-to-extend-runway-into-2027 Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027 https://ml.globenewswire.com/media/7b8bba27-38bb-484c-afef-fc5a539ec4e5/small/cerevance-logo-px-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244507-debra-hussain-joins-chiesi-usa-as-vice-president-and-business-unit-leader-u-s-care Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Debra Hussain Joins Chiesi USA as Vice President and Business Unit Leader, U.S. CARE https://ml.globenewswire.com/media/16391baf-8814-4a94-a863-8ac2f441d52b/small/chiesi-logo-1-primary-png.png https://www.healthreportequatorialguinea.com/article/912244655-lyell-immunopharma-announces-participation-in-may-investor-conferences Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Lyell Immunopharma Announces Participation in May Investor Conferences https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244823-gelteq-announces-usd-3-5-million-strategic-debt-financing-to-accelerate-commercialization-and-support-revenue-growth Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg https://www.healthreportequatorialguinea.com/article/912244826-ataibeckley-reports-first-quarter-2026-financial-results-and-provides-program-and-business-update Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.healthreportequatorialguinea.com/article/912244837-humacyte-appoints-dr-todd-e-rasmussen-as-chief-surgical-officer Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.healthreportequatorialguinea.com/article/912244843-positive-interim-phase-3-results-highlight-potential-of-ovaprene-novel-hormone-free-contraceptive Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive https://ml.globenewswire.com/media/deaaf9ba-24cc-4909-ab8d-1982b8b4e650/small/darebioscience-primarylogo-02-vertical-reg-orangebrown-wtrad.png https://www.healthreportequatorialguinea.com/article/912245000-brain-cancer-canada-awards-100-000-the-emily-mcintosh-brain-cancer-research-grant-to-advance-breakthrough-immunotherapy-for-glioblastoma Health Report Equatorial Guinea en PressRelease 2026-05-12T12:00:00+00:00 Brain Cancer Canada Awards $100,000 “The Emily McIntosh Brain Cancer Research Grant” to Advance Breakthrough Immunotherapy for Glioblastoma https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.healthreportequatorialguinea.com/article/912225800-mink-therapeutics-presents-clinical-evidence-that-a-single-off-the-shelf-inkt-cell-product-drives-context-dependent-immune-responses-at-asgct-2026 Health Report Equatorial Guinea en PressRelease 2026-05-12T11:35:30+00:00 MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026 https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.healthreportequatorialguinea.com/article/912225796-collegium-completes-acquisition-of-azstarys-from-corium-therapeutics Health Report Equatorial Guinea en PressRelease 2026-05-12T11:31:46+00:00 Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225292-aveanna-to-participate-at-the-william-blair-46th-annual-growth-stock-conference Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png https://www.healthreportequatorialguinea.com/article/912225295-sab-bio-reports-q1-2026-financial-results-and-recent-business-highlights Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://www.healthreportequatorialguinea.com/article/912225296-compass-therapeutics-to-participate-in-upcoming-may-investor-events Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Compass Therapeutics to Participate in Upcoming May Investor Events https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.healthreportequatorialguinea.com/article/912225385-sagimet-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.healthreportequatorialguinea.com/article/912225437-zevra-therapeutics-to-present-at-the-h-c-wainwright-bioconnect-investor-conference Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://www.healthreportequatorialguinea.com/article/912225444-mereo-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/d8cb3e79-0641-4cca-8687-15281f1437be/small/mereo-logo-full-colour-rgb-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225454-harvard-bioscience-announces-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Harvard Bioscience Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6784a4a6-c259-489c-8b5b-05266f41b06f/small/hbio-logo-png.png https://www.healthreportequatorialguinea.com/article/912225458-briacell-phase-3-bria-imt-study-enrollment-surpasses-230-patients Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225557-bridgebio-submits-nda-to-fda-for-encaleret-for-individuals-living-with-adh1 Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1 https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthreportequatorialguinea.com/article/912225573-vireo-growth-inc-announces-first-quarter-2026-results Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Vireo Growth Inc. Announces First Quarter 2026 Results https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://www.healthreportequatorialguinea.com/article/912225583-xilio-therapeutics-reports-first-quarter-2026-financial-results-and-provides-pipeline-and-business-updates Health Report Equatorial Guinea en PressRelease 2026-05-12T11:30:00+00:00 Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://www.healthreportequatorialguinea.com/article/912225309-neuraxis-reports-record-first-quarter-2026-financial-results-driven-by-80-year-over-year-revenue-growth Health Report Equatorial Guinea en PressRelease 2026-05-12T11:05:00+00:00 NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth https://ml.globenewswire.com/media/a1e3887d-3378-46c5-938d-2b0d5a7c825f/small/neuraxis-logo-png.png https://www.healthreportequatorialguinea.com/article/912225617-achieve-life-sciences-strengthens-board-and-commercial-leadership-with-three-senior-appointments-from-team-previously-at-verona-pharma Health Report Equatorial Guinea en PressRelease 2026-05-12T11:05:00+00:00 Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225676-arvinas-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Report Equatorial Guinea en PressRelease 2026-05-12T11:05:00+00:00 Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225336-corvel-corporation-to-host-live-earnings-release-webcast Health Report Equatorial Guinea en PressRelease 2026-05-12T11:02:00+00:00 CorVel Corporation to Host Live Earnings Release Webcast https://ml.globenewswire.com/media/dc150059-2d36-47de-9f10-e6f5990ba046/small/corvel-primary-full-color-png.png https://www.healthreportequatorialguinea.com/article/912225324-prelude-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Report Equatorial Guinea en PressRelease 2026-05-12T11:01:00+00:00 Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.healthreportequatorialguinea.com/article/912225276-proqr-announces-first-quarter-2026-operating-and-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 ProQR Announces First Quarter 2026 Operating and Financial Results https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.healthreportequatorialguinea.com/article/912225279-ac-immune-announces-retirement-of-ceo-dr-andrea-pfeifer-at-upcoming-agm Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225282-immatics-announces-first-quarter-2026-financial-results-and-business-update Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Immatics Announces First Quarter 2026 Financial Results and Business Update https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://www.healthreportequatorialguinea.com/article/912225288-novabridge-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png https://www.healthreportequatorialguinea.com/article/912225294-sionna-therapeutics-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Sionna Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://www.healthreportequatorialguinea.com/article/912225307-legend-biotech-reports-first-quarter-2026-results-and-recent-highlights Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Legend Biotech Reports First Quarter 2026 Results and Recent Highlights https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://www.healthreportequatorialguinea.com/article/912225344-foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-may Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225346-arbor-biotechnologies-achieves-unprecedented-precise-in-vivo-reverse-transcriptase-editing-in-the-brain-using-a-single-aav-vector-opening-a-new-path Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases https://ml.globenewswire.com/media/68842426-d5ae-4dd2-800a-89d80ad4b3b7/small/arbor-biotech-logo-web-3-1-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225350-tenax-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225358-cartesian-therapeutics-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.healthreportequatorialguinea.com/article/912225364-acumen-pharmaceuticals-reports-first-quarter-2026-financial-results-and-business-highlights Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://www.healthreportequatorialguinea.com/article/912225390-olema-oncology-reports-first-quarter-2026-financial-and-operating-results Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Olema Oncology Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.healthreportequatorialguinea.com/article/912225403-seres-therapeutics-to-participate-in-h-c-wainwright-4th-annual-bioconnect-investor-conference Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.healthreportequatorialguinea.com/article/912225448-opus-genetics-announces-financial-results-for-first-quarter-2026-and-provides-corporate-update Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225450-blue-point-brewing-launches-magic-hour-ipa-a-bright-tropical-6-abv-sipper-for-golden-hour Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour https://ml.globenewswire.com/media/aad05a49-5280-4153-9183-4a388fff0fcc/medium/blue-point-magic-hour.jpeg https://www.healthreportequatorialguinea.com/article/912225520-medicenna-and-fondazione-melanoma-onlus-announce-first-patient-dosed-in-the-neo-cyt-study-of-mdna11-in-neoadjuvant-melanoma Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.healthreportequatorialguinea.com/article/912225577-c4-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://www.healthreportequatorialguinea.com/article/912225615-achieve-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-updates Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225625-ovid-therapeutics-reports-business-updates-and-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225655-felix-health-to-lower-semaglutide-pricing-by-up-to-65-as-lower-cost-options-enter-canada Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Felix Health to Lower Semaglutide Pricing by Up to 65% as Lower-Cost Options Enter Canada https://ml.globenewswire.com/media/34f01f28-be97-40ad-8a49-b70850fe9f7d/small/orange-png.png https://www.healthreportequatorialguinea.com/article/912225672-arvinas-and-pfizer-enter-into-a-transaction-with-rigel-pharmaceuticals-for-the-exclusive-global-rights-of-veppanu-vepdegestrant Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant) https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225749-climb-bio-to-present-at-upcoming-investor-conferences Health Report Equatorial Guinea en PressRelease 2026-05-12T11:00:00+00:00 Climb Bio to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://www.healthreportequatorialguinea.com/article/912225600-promis-neurosciences-announces-first-quarter-2026-financial-results-and-provides-corporate-highlights Health Report Equatorial Guinea en PressRelease 2026-05-12T10:30:00+00:00 ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights https://ml.globenewswire.com/media/26bec3c9-ac4b-487b-ab90-3b62be29497d/small/promis-jpg.jpg https://www.healthreportequatorialguinea.com/article/912207091-75-years-of-care-leading-chinese-women-s-hospital-innovating-for-women-children-worldwide Health Report Equatorial Guinea en PressRelease 2026-05-12T10:03:14+00:00 75 Years of Care: Leading Chinese Women's Hospital Innovating for Women, Children Worldwide https://ml.globenewswire.com/Resource/Download/d349948a-0f24-4ccc-9e7c-140813f07c2d/hospital.jpg https://www.healthreportequatorialguinea.com/article/912206955-addition-therapeutics-presents-preclinical-proof-of-concept-data-at-american-society-of-gene-cell-therapy-asgct-29th-annual-meeting Health Report Equatorial Guinea en PressRelease 2026-05-12T10:00:00+00:00 Addition Therapeutics Presents Preclinical Proof-of-Concept Data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting https://ml.globenewswire.com/media/3f8d8448-ab3a-452a-be14-dfe5bcca35f1/small/addition-th-logo-white-bg-gnw-png.png https://www.healthreportequatorialguinea.com/article/912192662-ektah-shows-50-reduction-in-post-glp-1-weight-rebound-with-novel-obesity-treatment-and-reports-positive-phase-i-data Health Report Equatorial Guinea en PressRelease 2026-05-12T08:00:00+00:00 EktaH Shows ~50% Reduction in Post-GLP-1 Weight Rebound with Novel Obesity Treatment and Reports Positive Phase I Data https://ml-eu.globenewswire.com/media/Y2QzY2VmMTMtNzNhNy00MGVkLWEwODgtZWMyNWEzZWMwNmJhLTEwMzc0NTQtMjAyNi0wNS0xMi1lbg==/tiny/AKAMPION.png https://www.healthreportequatorialguinea.com/article/912192664-astronautx-builds-executive-team-with-appointment-of-experienced-clinical-development-leader-michelle-mellion-md-as-chief-medical-officer Health Report Equatorial Guinea en PressRelease 2026-05-12T07:30:00+00:00 AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer https://ml-eu.globenewswire.com/media/6e0a0d3c-d1a9-45de-82e7-1178a2900024/small/astronautx-logo-rgb-png.png https://www.healthreportequatorialguinea.com/article/912192666-vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system Health Report Equatorial Guinea en PressRelease 2026-05-12T07:30:00+00:00 ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System https://ml-eu.globenewswire.com/media/97cc2ebe-8f0d-4051-aca4-6350b6043071/small/vicentra-logo-png.png https://www.healthreportequatorialguinea.com/article/912192670-orion-animal-health-receives-us-fda-approval-for-tessie-tasipimidine-oral-solution-for-the-treatment-of-noise-aversion-and-separation-anxiety-in Health Report Equatorial Guinea en PressRelease 2026-05-12T07:30:00+00:00 Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.healthreportequatorialguinea.com/article/912192673-orion-animal-health-sai-fda-lta-myyntiluvan-tessie-tuotteelle-tasipimidiini-oraaliliuos Health Report Equatorial Guinea en PressRelease 2026-05-12T07:30:00+00:00 Orion Animal Health sai FDA:lta myyntiluvan Tessie®-tuotteelle (tasipimidiini oraaliliuos) https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.healthreportequatorialguinea.com/article/912177621-enterome-presents-phase-2-indolent-non-hodgkin-lymphoma-data-at-eha-showing-eo2463-induces-b-cell-target-specific-cd8-t-cell-expansion-correlating Health Report Equatorial Guinea en PressRelease 2026-05-12T06:30:00+00:00 Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes https://ml-eu.globenewswire.com/media/e04b919f-9b3c-4d80-af54-707d3fa48216/small/enterome-logo-png.png https://www.healthreportequatorialguinea.com/article/912177603-infex-therapeutics-secures-4-3-million-funding-to-advance-anti-infective-pipeline-targeting-drug-resistant-infections Health Report Equatorial Guinea en PressRelease 2026-05-12T06:00:00+00:00 Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections https://ml-eu.globenewswire.com/media/7e6719ab-feb1-4eb3-93c1-acca0cc4a3a1/small/infex-logo-png.png https://www.healthreportequatorialguinea.com/article/912143856-rapid-nutrition-extends-ai-powered-agentic-platform-to-consumer-ecosystem-following-investor-rollout Health Report Equatorial Guinea en PressRelease 2026-05-12T03:00:00+00:00 Rapid Nutrition Extends AI-Powered Agentic Platform to Consumer Ecosystem Following Investor Rollout https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.healthreportequatorialguinea.com/article/912126150-gala-health-glp-1-compounded-and-branded-weight-loss-medication-options-with-real-doctor-support Health Report Equatorial Guinea en PressRelease 2026-05-12T01:53:35+00:00 Gala Health GLP-1 Compounded and Branded Weight Loss Medication Options with Real Doctor Support https://zingfast.com/wp-content/uploads/2026/05/Gala-Health-GLP-1-Compounded-and-Branded-Weight-Loss-Medication-Options-with-Real-Doctor-Support.jpg https://www.healthreportequatorialguinea.com/article/912126135-enlitic-s-ensight-goes-live-at-rhcnz-advancing-radiology-workflow-efficiency-in-new-zealand Health Report Equatorial Guinea en PressRelease 2026-05-12T01:32:44+00:00 Enlitic’s Ensight Goes Live at RHCNZ, Advancing Radiology Workflow Efficiency in New Zealand https://ml.globenewswire.com/media/998557dc-9a0b-48b9-bfbc-579da6b75660/medium/enlitics-ensight-goes-live-at-rhcnz.jpg https://www.healthreportequatorialguinea.com/article/912106868-delos-capital-and-ap-biosciences-inc-launch-collaboration-to-create-new-biotech-companies-focused-on-next-generation-antibodies Health Report Equatorial Guinea en PressRelease 2026-05-12T00:00:00+00:00 Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies https://ml.globenewswire.com/media/92753de3-30bd-49fa-bc78-264699195351/small/logo-png.png https://www.healthreportequatorialguinea.com/article/912071498-macrogenics-to-sell-gmp-manufacturing-operations-to-bora-pharmaceuticals Health Report Equatorial Guinea en PressRelease 2026-05-11T21:20:43+00:00 MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png https://www.healthreportequatorialguinea.com/article/912071488-biocardia-to-host-q1-2026-financial-results-and-corporate-update-conference-call-on-may-15-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T21:10:39+00:00 BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026 https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.healthreportequatorialguinea.com/article/912071358-correction-human-appeal-launches-hajj-step-challenge-turning-steps-into-a-lifeline Health Report Equatorial Guinea en PressRelease 2026-05-11T21:04:51+00:00 CORRECTION – Human Appeal Launches Hajj Step Challenge, Turning Steps into a Lifeline https://ml-eu.globenewswire.com/media/6d57b095-4239-423a-bc6a-62d104c91ba8/small/human-appeal-logo-440-jpg.jpg https://www.healthreportequatorialguinea.com/article/912071471-biomea-fusion-reports-first-quarter-2026-financial-results-and-corporate-highlights Health Report Equatorial Guinea en PressRelease 2026-05-11T20:54:51+00:00 Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/d2f051eb-da8d-4233-9093-8ff1579d035f/small/biomea-fusion-logo-rgb-rev2-email-png.png https://www.healthreportequatorialguinea.com/article/912071458-sanara-medtech-inc-reports-first-quarter-2026-financial-results-unaudited Health Report Equatorial Guinea en PressRelease 2026-05-11T20:50:00+00:00 Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) https://ml.globenewswire.com/media/591eb30b-d3e4-428c-9cd6-536215925b01/small/logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912056025-sotera-health-announces-secondary-offering-of-common-stock Health Report Equatorial Guinea en PressRelease 2026-05-11T20:33:27+00:00 Sotera Health Announces Secondary Offering of Common Stock https://ml.globenewswire.com/media/a0ec722c-ad65-4f05-a8ae-bc1aa6cc4db4/small/sotera-png.png https://www.healthreportequatorialguinea.com/article/912055557-tonix-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-highlights Health Report Equatorial Guinea en PressRelease 2026-05-11T20:30:00+00:00 Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055813-steris-announces-financial-results-for-fiscal-2026-fourth-quarter-and-full-year Health Report Equatorial Guinea en PressRelease 2026-05-11T20:30:00+00:00 STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055909-cellectis-reports-financial-results-for-the-first-quarter-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T20:30:00+00:00 Cellectis Reports Financial Results for the First Quarter 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.healthreportequatorialguinea.com/article/912055924-cellectis-publie-ses-r-sultats-financiers-du-premier-trimestre-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T20:30:00+00:00 Cellectis publie ses résultats financiers du premier trimestre 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.healthreportequatorialguinea.com/article/912055999-scynexis-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Report Equatorial Guinea en PressRelease 2026-05-11T20:23:30+00:00 SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/4171e010-3103-4d21-b1c5-5b1c27927dce/small/scyxprimarysmall-png.png https://www.healthreportequatorialguinea.com/article/912055968-fda-advances-drug-repurposing-to-address-unmet-medical-needs Health Report Equatorial Guinea en PressRelease 2026-05-11T20:17:32+00:00 FDA Advances Drug Repurposing to Address Unmet Medical Needs https://ml.globenewswire.com/media/YzZiZmY2MzEtODkxYS00MGY1LWFlOTEtOTVhMGY2MWU5NjQyLTUwMDE1NDE1NC0yMDI2LTA1LTExLWVu/tiny/FDA.png https://www.healthreportequatorialguinea.com/article/912055947-solana-company-to-release-first-quarter-2026-operating-results-on-may-15-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T20:16:12+00:00 Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026 https://ml.globenewswire.com/media/1986b97e-8656-4213-9218-ae51324d696d/small/solana-company-main-black-png.png https://www.healthreportequatorialguinea.com/article/912055352-cg-oncology-s-presence-at-american-urological-association-aua-annual-meeting-underscores-its-strong-commitment-to-nmibc Health Report Equatorial Guinea en PressRelease 2026-05-11T20:15:00+00:00 CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055548-pharvaris-announces-closing-of-132-3-million-underwritten-offering-of-ordinary-shares-and-full-exercise-of-underwriters-option-to-purchase Health Report Equatorial Guinea en PressRelease 2026-05-11T20:15:00+00:00 Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.healthreportequatorialguinea.com/article/912055902-catalyst-pharmaceuticals-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:12:45+00:00 Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg https://www.healthreportequatorialguinea.com/article/912055278-si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance Health Report Equatorial Guinea en PressRelease 2026-05-11T20:09:00+00:00 SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance https://ml.globenewswire.com/media/1630843d-d109-4819-9c6f-455c684690ba/small/sibn-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912054638-oculis-reports-q1-2026-financial-results-and-provides-company-update Health Report Equatorial Guinea en PressRelease 2026-05-11T20:07:00+00:00 Oculis Reports Q1 2026 Financial Results and Provides Company Update https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.healthreportequatorialguinea.com/article/912054640-abivax-announces-results-of-its-may-11-2026-annual-general-meeting Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Abivax Announces Results of its May 11, 2026 Annual General Meeting https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://www.healthreportequatorialguinea.com/article/912054689-outset-medical-to-present-at-rbc-global-healthcare-conference Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Outset Medical to Present at RBC Global Healthcare Conference https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png https://www.healthreportequatorialguinea.com/article/912054998-cvrx-reports-first-quarter-2026-financial-and-operating-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 CVRx Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.healthreportequatorialguinea.com/article/912055141-roivant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may-20-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026 https://ml.globenewswire.com/media/f1a5db68-ee4f-437f-b4e6-2b840ae6a536/small/roivantlogo-png.png https://www.healthreportequatorialguinea.com/article/912055272-ceribell-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Ceribell Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.healthreportequatorialguinea.com/article/912055287-pliant-therapeutics-provides-corporate-update-and-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055301-harrow-announces-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Harrow Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/8e0382bf-e00a-4591-87aa-4e90001aabea/small/bw-harrow-logo-cmyk-wtag-wr-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055312-metagenomi-therapeutics-reports-business-updates-and-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7680f6bf-0803-4567-93bd-b52fc13a7887/small/new-mgx-logo-png.png https://www.healthreportequatorialguinea.com/article/912055322-sana-biotechnology-reports-first-quarter-2026-financial-results-and-business-updates Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055377-elicio-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/d588dddd-266e-4f3e-930a-d4c5ba15fe31/small/logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055470-lenz-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/e058841a-d17f-4fd7-b817-0b2c8e6cb656/small/lenz-png.png https://www.healthreportequatorialguinea.com/article/912055483-sangamo-therapeutics-announces-first-quarter-2026-earnings-call Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Sangamo Therapeutics Announces First Quarter 2026 Earnings Call https://ml.globenewswire.com/media/e3084490-aff3-4c15-8036-d94123563fd0/small/sangamo-logotm-11-11zon-png.png https://www.healthreportequatorialguinea.com/article/912055594-immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may-20 Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026  https://ml.globenewswire.com/media/7062c765-82cc-4ba2-ba1f-4b1396b9b052/small/immulogo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055613-amwell-to-participate-in-upcoming-investor-conference Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Amwell® to Participate in Upcoming Investor Conference https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://www.healthreportequatorialguinea.com/article/912055703-kyntra-bio-reports-first-quarter-2026-financial-results-and-provides-business-update Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png https://www.healthreportequatorialguinea.com/article/912055764-health-catalyst-reports-first-quarter-2026-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Health Catalyst Reports First Quarter 2026 Results https://ml.globenewswire.com/media/30a46956-a31b-4842-970b-df68aca246d2/medium/dos-related-arr-potential-2026-and-2027-impact.jpg https://www.healthreportequatorialguinea.com/article/912055780-coherus-oncology-reports-first-quarter-2026-financial-results-and-provides-business-update Health Report Equatorial Guinea en PressRelease 2026-05-11T20:05:00+00:00 Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png https://www.healthreportequatorialguinea.com/article/912055790-eikon-therapeutics-reports-first-quarter-2026-financial-results-and-provides-clinical-updates Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:57+00:00 Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates https://ml.globenewswire.com/media/02bfb0a7-27fe-4be6-b2f9-bc6eaf27b1d9/small/eikon-logo-jpg.jpg https://www.healthreportequatorialguinea.com/article/912054692-aura-biosciences-reports-first-quarter-2026-financial-results-and-business-highlights Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055004-arrivent-biopharma-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 ArriVent BioPharma Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/fc6761bf-9c47-4e62-ba46-f7c10eefe6bc/small/arrivent-logo-final-png.png https://www.healthreportequatorialguinea.com/article/912055156-aktis-oncology-reports-financial-results-and-business-highlights-for-first-quarter-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026 https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.healthreportequatorialguinea.com/article/912055268-atyr-pharma-provides-regulatory-and-clinical-update-for-efzofitimod-in-pulmonary-sarcoidosis-following-fda-type-c-meeting Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting https://ml.globenewswire.com/media/d9b4b478-f8bd-4014-91ed-429caab67931/small/atyr-logo-png.png https://www.healthreportequatorialguinea.com/article/912055284-septerna-highlights-business-progress-and-reports-first-quarter-2026-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/8c635733-2794-456f-9bc4-3b53908acba9/small/septernalogo-black-10x-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055351-erasca-reports-first-quarter-2026-business-updates-and-financial-results Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 Erasca Reports First Quarter 2026 Business Updates and Financial Results https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://www.healthreportequatorialguinea.com/article/912055378-skye-bioscience-reports-first-quarter-2026-financial-results-and-business-update Health Report Equatorial Guinea en PressRelease 2026-05-11T20:01:00+00:00 Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://www.healthreportequatorialguinea.com/article/912055757-portsmouth-square-inc-reports-third-quarter-fiscal-2026-results-hotel-operating-results-improve-year-over-year-as-san-francisco-recovery-progresses Health Report Equatorial Guinea en PressRelease 2026-05-11T19:55:00+00:00 Portsmouth Square, Inc. Reports Third Quarter Fiscal 2026 Results; Hotel Operating Results Improve Year‑Over‑Year as San Francisco Recovery Progresses https://ml.globenewswire.com/media/ODMwNjRiOTItYzBiNy00ZGRmLWFiZDQtZDkwYTdiODRhZmZlLTUwMDEzNDUwMC0yMDI2LTA1LTExLWVu/tiny/Portsmouth-Square-Inc.png https://www.healthreportequatorialguinea.com/article/912054663-human-appeal-launches-global-step-challenge-turning-steps-into-worship-and-a-lifeline-for-families-this-hajj Health Report Equatorial Guinea en PressRelease 2026-05-11T19:33:00+00:00 Human Appeal Launches Global Step Challenge, Turning Steps into Worship and a Lifeline for Families this Hajj https://ml-eu.globenewswire.com/media/6d57b095-4239-423a-bc6a-62d104c91ba8/small/human-appeal-logo-440-jpg.jpg https://www.healthreportequatorialguinea.com/article/912038190-penn-highlands-healthcare-addresses-emergency-medical-services-and-transportation Health Report Equatorial Guinea en PressRelease 2026-05-11T19:19:27+00:00 Penn Highlands Healthcare Addresses Emergency Medical Services and Transportation https://ml.globenewswire.com/media/OTIwYjY4YWMtNzExZi00ODFiLTk0ZmQtNzZjODdmZTM5Zjg0LTEyNTYxMzgtMjAyNi0wNS0xMS1lbg==/tiny/Penn-Highlands-Healthcare.png https://www.healthreportequatorialguinea.com/article/912038087 Health Report Equatorial Guinea en PressRelease 2026-05-11T18:26:09+00:00 ダークホース・コンサルティング・グループと昆拓、細胞・遺伝子治療開発企業向けに中国での臨床開発を加速させる覚書の締結を発表 https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912038116-dark-horse-consulting-group-kuntuo Health Report Equatorial Guinea en PressRelease 2026-05-11T18:26:09+00:00 다크 호스 컨설팅 그룹 (Dark Horse Consulting Group)과 쿤퉈 (KunTuo), 중국 내 세포·유전자 치료제 임상 개발 가속화를 위한 양해각서 체결 발표 https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912038118-dark-horse-consulting-group-dan-kuntuo-mengumumkan-memorandum-persefahaman-bagi-menyediakan-laluan-dipercepatkan-ke-arah-pembangunan-klinikal-di-china Health Report Equatorial Guinea en PressRelease 2026-05-11T18:26:09+00:00 Dark Horse Consulting Group dan KunTuo Mengumumkan Memorandum Persefahaman bagi Menyediakan Laluan Dipercepatkan ke Arah Pembangunan Klinikal di China untuk Pembangun Terapi Sel dan Gen https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912038124-dark-horse-consulting-group-kuntuo Health Report Equatorial Guinea en PressRelease 2026-05-11T18:26:09+00:00 Dark Horse Consulting Group 与 KunTuo 宣布签署谅解备忘录，为细胞和基因疗法研发企业提供加速中国临床研发的途径 https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912038129-dark-horse-consulting-group-kuntuo Health Report Equatorial Guinea en PressRelease 2026-05-11T18:26:09+00:00 Dark Horse Consulting Group 與 KunTuo 宣佈簽署諒解備忘錄，讓細胞與基因治療開發商能夠加快在中國臨床開發 https://ml.globenewswire.com/media/b96e7c60-949b-4a7d-9d4e-8d9766cf8c87/small/2025-dhcg-logo-color-jpg.jpg https://www.healthreportequatorialguinea.com/article/912022499-ai-transforms-pharmaceutical-packaging-as-industry-invests-billions-in-zero-defect-quality-control-systems Health Report Equatorial Guinea en PressRelease 2026-05-11T18:00:17+00:00 AI Transforms Pharmaceutical Packaging as Industry Invests Billions in Zero-Defect Quality Control Systems https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.healthreportequatorialguinea.com/article/912022472-youth-leaders-empowering-young-students-with-lifesaving-skills-act-high-school-cpr-program-in-action Health Report Equatorial Guinea en PressRelease 2026-05-11T17:34:02+00:00 Youth Leaders Empowering Young Students with Lifesaving Skills: ACT High School CPR Program in Action https://ml.globenewswire.com/media/85cf88a5-7cf3-4c15-9cc1-c70e9add6566/medium/youth-leaders-empowering-young-students-with-lifesaving-skil.jpg https://www.healthreportequatorialguinea.com/article/912022477-de-jeunes-leaders-transmettent-des-comp-tences-qui-sauvent-des-vies-aux-l-ves-du-primaire-le-programme-de-rcr-et-dea-au-secondaire-d-act-en-action Health Report Equatorial Guinea en PressRelease 2026-05-11T17:34:02+00:00 De jeunes leaders transmettent des compétences qui sauvent des vies aux élèves du primaire : Le programme de RCR et DEA au secondaire d’ACT en action https://ml.globenewswire.com/media/85cf88a5-7cf3-4c15-9cc1-c70e9add6566/medium/de-jeunes-leaders-transmettent-des-competences-qui-sauvent-d.jpg https://www.healthreportequatorialguinea.com/article/912022396-genfit-annual-combined-general-meeting-of-june-15-2026-availability-of-preparatory-documents Health Report Equatorial Guinea en PressRelease 2026-05-11T17:00:00+00:00 GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents https://ml-eu.globenewswire.com/media/ZmZlMTYwYTItZjVhZS00YmY2LThmMzMtMDkyY2FjZGFiZTlmLTEwMTEyNjgtMjAyNi0wNS0xMS1lbg==/tiny/GENFIT-S-A-.png https://www.healthreportequatorialguinea.com/article/912022403-genfit-assembl-e-g-n-rale-mixte-du-15-juin-2026-modalit-s-de-mise-disposition-des-documents-pr-paratoires Health Report Equatorial Guinea en PressRelease 2026-05-11T17:00:00+00:00 GENFIT : Assemblée Générale Mixte du 15 juin 2026 — modalités de mise à disposition des documents préparatoires   https://ml-eu.globenewswire.com/media/ZmZlMTYwYTItZjVhZS00YmY2LThmMzMtMDkyY2FjZGFiZTlmLTEwMTEyNjgtMjAyNi0wNS0xMS1mcg==/tiny/GENFIT-S-A-.png https://www.healthreportequatorialguinea.com/article/912008859-lumenis-stellar-m22-with-xpl-technology-named-best-new-dermatology-technology-solution-in-2026-medtech-breakthrough-awards-program Health Report Equatorial Guinea en PressRelease 2026-05-11T16:49:39+00:00 Lumenis Stellar M22™ with XPL Technology Named “Best New Dermatology Technology Solution” in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthreportequatorialguinea.com/article/912008700-nextel-medical-corp-enters-final-stage-for-commercial-launch-sets-sights-on-revenue-generation-and-otcqb-uplist Health Report Equatorial Guinea en PressRelease 2026-05-11T15:53:17+00:00 NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist https://ml.globenewswire.com/media/ZTM1NzZjOWMtZjE4YS00ZDE3LTg2ODYtZWEyMWUwNjgxNjhjLTUwMDE1ODM1Mi0yMDI2LTA1LTExLWVu/tiny/Exousia-Pro-Inc-.png https://www.healthreportequatorialguinea.com/article/912008671-joyce-university-honors-more-than-6-600-nurses-and-nursing-students-during-national-nurses-day-celebration Health Report Equatorial Guinea en PressRelease 2026-05-11T15:43:22+00:00 Joyce University Honors More Than 6,600 Nurses and Nursing Students During National Nurses Day Celebration https://ml.globenewswire.com/media/ZGZkZjIyNzItZjhkNy00MDcxLTk1NTAtMTI0ZGVhMDIyMDE4LTUwMDE2MDk1Mi0yMDI2LTA1LTExLWVu/tiny/Joyce-University-of-Nursing-an.png https://www.healthreportequatorialguinea.com/article/911995166-pheast-therapeutics-presents-preclinical-data-on-phst677-a-novel-bispecific-adc-targeting-cdh1-and-nectin-4-at-pegs-boston-summit-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T15:30:00+00:00 Pheast Therapeutics Presents Preclinical Data on PHST677, a Novel Bispecific ADC Targeting CDH1 and Nectin-4 at PEGS Boston Summit 2026 https://ml.globenewswire.com/media/f27ab630-f23c-44f6-aae6-6fae240628af/small/pheast-logo-full-color-gradient-high-res-jpg.jpg https://www.healthreportequatorialguinea.com/article/911995344-progyny-inc-to-present-at-bofa-securities-2026-health-care-conference Health Report Equatorial Guinea en PressRelease 2026-05-11T14:57:11+00:00 Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://www.healthreportequatorialguinea.com/article/911995238-team-vision-media-launches-clarity-in-care-to-address-communication-failures-in-healthcare Health Report Equatorial Guinea en PressRelease 2026-05-11T14:50:00+00:00 Team Vision Media Launches "Clarity in Care" to Address Communication Failures in Healthcare https://pressranger.s3.us-west-1.amazonaws.com/3267380/1000145370.png https://www.healthreportequatorialguinea.com/article/911981428-cytokinetics-announces-new-data-related-to-myqorzo-aficamten-at-esc-heart-failure-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T14:06:00+00:00 Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026 https://ml.globenewswire.com/media/5179347f-327c-44f4-9e9c-4e74b9ade881/medium/figure-1-dose-dependent-effects-of-aficamten-compared-with-m.png https://www.healthreportequatorialguinea.com/article/911981535-plan-d-action-en-pr-vention-la-coalition-qu-b-coise-pour-la-r-duction-de-la-maladie-salue-le-d-voilement Health Report Equatorial Guinea en PressRelease 2026-05-11T14:04:51+00:00 Plan d'action en prévention : La Coalition québécoise pour la réduction de la maladie salue le dévoilement https://ml.globenewswire.com/media/d08d28a1-d1c3-4a4a-a82e-6e41f9a9e9dd/small/aspq-1-png.JPG https://www.healthreportequatorialguinea.com/article/911981308-national-nurses-week-simple-modern-partners-with-four-hospitals-to-support-nurses Health Report Equatorial Guinea en PressRelease 2026-05-11T14:00:00+00:00 National Nurses Week: Simple Modern Partners with Four Hospitals to Support Nurses https://ml.globenewswire.com/media/Mzg3Y2ZlMTYtNDA4Ni00YjM1LWFhMGUtNmViMDYwZWFhYzNlLTUwMDE0OTM4Mi0yMDI2LTA1LTExLWVu/tiny/Simple-Modern.png https://www.healthreportequatorialguinea.com/article/911981349-110-years-110-stories-110-reasons-to-raise-awareness-for-gbs Health Report Equatorial Guinea en PressRelease 2026-05-11T14:00:00+00:00 110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS https://ml.globenewswire.com/media/cd44ffa5-89d9-447b-b8b6-123bab39258b/small/gbs-cidp-logo-png.png https://www.healthreportequatorialguinea.com/article/911981391-acoramidis-continues-to-demonstrate-disease-modifying-effects-in-attr-cm-reducing-sttr-variability-and-outpatient-worsening-heart-failure Health Report Equatorial Guinea en PressRelease 2026-05-11T13:30:00+00:00 Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthreportequatorialguinea.com/article/911981486-lifeward-to-report-first-quarter-2026-financial-results-on-may-15-2026 Health Report Equatorial Guinea en PressRelease 2026-05-11T13:25:58+00:00 Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026 https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://www.healthreportequatorialguinea.com/article/911970095-biodesix-announces-ats-2026-presentations-providing-real-world-clinical-evidence-and-healthcare-system-economic-value-for-nodify-lung-testing Health Report Equatorial Guinea en PressRelease 2026-05-11T13:17:00+00:00 Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://www.healthreportequatorialguinea.com/article/911970057-ernexa-therapeutics-releases-virtual-investor-kol-connect-segment-highlighting-ovarian-cancer-landscape-and-lead-candidate-erna-101 Health Report Equatorial Guinea en PressRelease 2026-05-11T13:15:00+00:00 Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101 https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.healthreportequatorialguinea.com/article/911970069-anaptys-appoints-chris-murphy-as-chief-financial-officer-and-owen-hughes-to-board-of-directors Health Report Equatorial Guinea en PressRelease 2026-05-11T13:15:00+00:00 Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.healthreportequatorialguinea.com/article/911970214-work-medical-collaborates-with-novabioplus-to-unlock-biological-data-value-with-ai-advancing-the-biotoken-assetization-model Health Report Equatorial Guinea en PressRelease 2026-05-11T13:15:00+00:00 WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model https://ml.globenewswire.com/media/7c9dd1a3-c713-4b34-820d-2c5ef0c0e8b7/small/wok-logo-png.png